Submission of copies of Newspaper Advertisement pursuant to Regulation 47 and 52(8) of SEBI(LODR), 2015
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Gujarat Terce Laboratories submitted copies of newspaper advertisements (published in Business Standard and Jay Hind on May 28, 2025) containing its audited financial results for Q4 and FY ended March 31, 2025, as required under SEBI LODR Regulations. Total income from operations for FY25 stood at Rs 5,019.52 lakhs, up marginally from Rs 4,797.47 lakhs in FY24. Net profit before tax jumped to Rs 339.04 lakhs (vs Rs 54.39 lakhs last year), reflecting strong operating performance. However, the company swung to a net loss after tax of Rs 97.87 lakhs in FY25, compared to a profit of Rs 24.34 lakhs in FY24, likely due to deferred tax adjustments or one-time tax charges. In Q4 alone, profit before tax was Rs 96.83 lakhs but the company posted a loss after tax of Rs 339.14 lakhs, with diluted EPS turning negative at Rs 4.35 (vs Rs 0.73).
Despite higher revenue and strong pre-tax profits, the swing to a net loss after tax in both Q4 and FY25 is negative for shareholders and signals significant tax-related or deferred tax adjustments. Investors should watch for clarity on the tax provisions in the detailed results.